174 related articles for article (PubMed ID: 33846154)
1. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
[TBL] [Abstract][Full Text] [Related]
2. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
4. Evaluating breast cancer risk projections for Hispanic women.
Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
[TBL] [Abstract][Full Text] [Related]
5. Validation of a genetic risk score for Arkansas women of color.
Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
[TBL] [Abstract][Full Text] [Related]
6. Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models.
Li SX; Milne RL; Nguyen-Dumont T; Wang X; English DR; Giles GG; Southey MC; Antoniou AC; Lee A; Li S; Winship I; Hopper JL; Terry MB; MacInnis RJ
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 33977228
[TBL] [Abstract][Full Text] [Related]
7. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
[TBL] [Abstract][Full Text] [Related]
8. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
[TBL] [Abstract][Full Text] [Related]
9. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
[TBL] [Abstract][Full Text] [Related]
10. Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE.
Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
Prev Med Rep; 2022 Feb; 25():101678. PubMed ID: 35127357
[TBL] [Abstract][Full Text] [Related]
11. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
Pal Choudhury P; Wilcox AN; Brook MN; Zhang Y; Ahearn T; Orr N; Coulson P; Schoemaker MJ; Jones ME; Gail MH; Swerdlow AJ; Chatterjee N; Garcia-Closas M
J Natl Cancer Inst; 2020 Mar; 112(3):278-285. PubMed ID: 31165158
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
Dite GS; MacInnis RJ; Bickerstaffe A; Dowty JG; Allman R; Apicella C; Milne RL; Tsimiklis H; Phillips KA; Giles GG; Terry MB; Southey MC; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):359-65. PubMed ID: 26677205
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
14. Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
Ghoncheh M; Ziaee F; Karami M; Poorolajal J
Clin Breast Cancer; 2017 Jun; 17(3):e113-e118. PubMed ID: 28216418
[TBL] [Abstract][Full Text] [Related]
15. Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models.
Li SX; Milne RL; Nguyen-Dumont T; English DR; Giles GG; Southey MC; Antoniou AC; Lee A; Winship I; Hopper JL; Terry MB; MacInnis RJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680343
[TBL] [Abstract][Full Text] [Related]
16. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.
McCarthy AM; Armstrong K; Handorf E; Boghossian L; Jones M; Chen J; Demeter MB; McGuire E; Conant EF; Domchek SM
Breast Cancer Res Treat; 2013 Apr; 138(3):889-98. PubMed ID: 23474973
[TBL] [Abstract][Full Text] [Related]
17. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
[TBL] [Abstract][Full Text] [Related]
18. Utilization of a breast cancer risk assessment tool by internal medicine residents in a primary care clinic: impact of an educational program.
Yadav S; Hartkop S; Cardenas PY; Ladkany R; Halalau A; Shoichet S; Maddens M; Zakalik D
BMC Cancer; 2019 Mar; 19(1):228. PubMed ID: 30871497
[TBL] [Abstract][Full Text] [Related]
19. Polygenic risk scores for prediction of breast cancer in Korean women.
Jee YH; Ho WK; Park S; Easton DF; Teo SH; Jung KJ; Kraft P
Int J Epidemiol; 2023 Jun; 52(3):796-805. PubMed ID: 36343017
[TBL] [Abstract][Full Text] [Related]
20. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
